Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/53446
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorProudman, S.-
dc.contributor.authorCleland, L.-
dc.contributor.authorJames, M.-
dc.date.issued2008-
dc.identifier.citationRheumatic Disease Clinics of North America, 2008; 34(2):469-479-
dc.identifier.issn0889-857X-
dc.identifier.issn1558-3163-
dc.identifier.urihttp://hdl.handle.net/2440/53446-
dc.description.abstractThere is high level evidence (meta-analysis of randomized, controlled trials) for symptomatic benefits from fish oil use in rheumatoid arthritis, and there is biologic plausibility for its clinical effects. Fish oil also has safety advantages in reducing cardiovascular risk via direct cardiovascular effects and via nonsteroidal anti-inflammatory drug-sparing. This is an important aspect of fish oil use, given the increased cardiovascular risk in rheumatoid arthritis. Perceived barriers to clinical use are readily addressed.-
dc.description.statementofresponsibilitySusanna M. Proudman, Leslie G. Cleland and Michael J. James-
dc.language.isoen-
dc.publisherW B Saunders Co-
dc.source.urihttp://dx.doi.org/10.1016/j.rdc.2008.03.003-
dc.subjectHumans-
dc.subjectArthritis, Rheumatoid-
dc.subjectInflammation-
dc.subjectDietary Fats-
dc.subjectFatty Acids, Omega-3-
dc.subjectRandomized Controlled Trials as Topic-
dc.titleDietary omega-3 fats for treatment of inflammatory joint disease: Efficacy and utility-
dc.typeJournal article-
dc.identifier.doi10.1016/j.rdc.2008.03.003-
pubs.publication-statusPublished-
dc.identifier.orcidProudman, S. [0000-0002-3046-9884]-
dc.identifier.orcidJames, M. [0000-0002-4918-2998]-
Appears in Collections:Aurora harvest 5
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.